A Chlamydomonas-Derived Human Papillomavirus 16 E7 Vaccine Induces Specific Tumor Protection

BACKGROUND: The E7 protein of the Human Papillomavirus (HPV) type 16, being involved in malignant cellular transformation, represents a key antigen for developing therapeutic vaccines against HPV-related lesions and cancers. Recombinant production of this vaccine antigen in an active form and in com...

Descripción completa

Detalles Bibliográficos
Autores principales: Demurtas, Olivia C., Massa, Silvia, Ferrante, Paola, Venuti, Aldo, Franconi, Rosella, Giuliano, Giovanni
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3634004/
https://www.ncbi.nlm.nih.gov/pubmed/23626690
http://dx.doi.org/10.1371/journal.pone.0061473

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3634004/
https://www.ncbi.nlm.nih.gov/pubmed/23626690
http://dx.doi.org/10.1371/journal.pone.0061473

Ejemplares similares